Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Qcsine
- Development stage
- Preclinical
- Lead developer
- Intra Life
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Qcsine (also known as Qcsine-Softgel) is a fixed-dose combination nutraceutical supplement developed and marketed by Intra Life. It is formulated as an oral softgel capsule containing coenzyme Q10 (100 mg), piperine (5 mg), and omega-3 fatty acids (90 mg eicosapentaenoic acid [EPA] and 60 mg docosahexaenoic acid [DHA]). Qcsine is designed to support cardiovascular health, cholesterol control, cognitive function, and antioxidant defense. Coenzyme Q10 serves as an essential cofactor in mitochondrial electron transport and acts as a lipid-soluble antioxidant. Omega-3 fatty acids support lipid metabolism and cognitive health, while piperine is included to enhance the bioavailability and absorption of the other active ingredients by inhibiting metabolic enzymes and efflux transporters.
- Brand names
- QcsineQcsine-Softgel
- Other names
- Co-Enzyme Q10 + Piperine + Omega-3 Fatty AcidsCoenzyme Q10 + Piperine + Omega-3 Fatty Acids
02
Targets
CYP3A4 (Cytochrome P450 3A4)FFAR4 (Free fatty acid receptor 4)ABCB1 (P-glycoprotein)NADH:ubiquinone oxidoreductase subunit familyPPARA (Peroxisome proliferator-activated receptor alpha)PPARG (Peroxisome proliferator-activated receptor gamma)SDHD (Succinate dehydrogenase cytochrome b small subunit)
Beyond the preview
Go deeper on Qcsine.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Qcsine.